Sign in Subscribe
Vaccines

FDA Restricts COVID-19 Vaccine Use, Changing U.S. Policy on Annual Shots

Strategic Insights

— 2 min read

Regulators in the U.S. have approved but limited the use of COVID-19 vaccines for many Americans. The new shots, produced by Pfizer and Moderna, are approved for all seniors but for younger adults and those with high-risk health conditions. This change affects millions of Americans who will have to prove their risk to receive the vaccine, and millions more who may want to get vaccinated but suddenly no longer qualify. The FDA has also revoked the emergency authorization for Pfizer's vaccine in children under 5, leaving Moderna as the only provider of shots for that age group.

Key Takeaways:

  • The FDA has approved but restricted the use of COVID-19 vaccines for many Americans, with Pfizer's vaccine available for seniors and Moderna's vaccine available for seniors and those with high-risk health conditions.
  • Millions of Americans will have to prove their risk to receive the vaccine, and millions more may want to get vaccinated but no longer qualify.
  • Pfizer's vaccine is no longer available for children under 5, and Moderna's vaccine is only available for children with at least one serious health problem.
  • The FDA's new policy reflects a shift in the ongoing risks of COVID-19, and yearly booster shots are recommended by health officials.
  • The restrictions on COVID-19 vaccine use could create barriers to vaccinations and cause confusion for patients, doctors, and pharmacists.
  • Some medical groups, including the American Academy of Pediatrics, have objected to the restrictions, saying they may block vaccine access for families who want to protect their children.
  • The new limits on vaccine use will likely be decided by federal health advisers, health insurers, pharmacies, and state authorities.

Statistics:

  • 47,500 Americans died from COVID-related causes last year, according to preliminary data from the CDC.
  • The FDA expects to receive over 10 million doses from Pfizer and Moderna's new vaccine batches.
  • 70% of Americans have received at least one COVID-19 vaccine, according to CDC data.
  • The U.S. has administered over 600 million COVID-19 vaccine doses, according to CDC data.
  • Pfizer and Moderna's new vaccines target coronavirus subtypes that are closely related to some newly emerging cousins.
  • Novavax's vaccine is expected in the early fall, with over 10 million doses planned.

Sources:

  • The Associated Press article (no date)
  • CDC data
  • FDA press release (no date)
  • Novavax press release (no date)
  • American Academy of Pediatrics statement (no date)
  • Infectious Diseases Society of America statement (no date)

Read more